Drug class in one race
IL-2 receptor drugs for Non-Small Cell Lung Cancer
3 tracked IL-2 receptor drugs in the Non-Small Cell Lung Cancer race. The class explanation lives on the IL-2 receptor page; the full indication pipeline across every mechanism is on the Non-Small Cell Lung Cancer page.
1 Phase 21 Phase 1/21 preclinical / unstaged